224 - Immunosuppression and RSV Prefusion F Protein Vaccine Effectiveness in Older Adults: A Prespecified Subanalysis from the DAN-RSV Trial

Presenting Author(s)

• AR

  Anne Marie Reimer Jensen, MD

  Copenhagen University Hospital - Herlev and Gentofte
  Copenhagen, Hovedstaden, Denmark

  Slides

Co-Author(s)

• ML

  Mats CH Lassen, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• NJ

  Niklas D. Johansen, MD, PhD

  Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark
  Copenhagen, Hovedstaden, Denmark
• SC

  Sine H. Christensen, MSc

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• NA

  Negar Aliabadi, MD, MS

  Director
  Pfizer
  New York, NY, United States
• KS

  Kristoffer Skaarup, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• DM

  Daniel Modin, MD

  Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark
  Copenhagen, Hovedstaden, Denmark
• KJ

  Kira Janstrup, PhD

  Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark
  Copenhagen, Hovedstaden, Denmark
• BC

  Brian L. Claggett, PhD

  Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  Boston, Massachusetts, United States
• CL

  Carsten S. Larsen, MD, DMSc

  Aarhus University Hospital
  Aarhus, Midtjylland, Denmark
• LL

  Lykke Larsen, MD, PhD

  Odense University Hospital
  Odense, Syddanmark, Denmark
• LW

  Lothar Wiese, MD, PhD, MIH

  Roskilde Hospital
  Roskilde, Sjelland, Denmark
• ML

  Matias G. Lindholm, MD

  Zealand University Hospital
  Copenhagen, Hovedstaden, Denmark
• MD

  Michael Dalager-Pedersen, MD PhD

  Doctor
  Aalborg University Hospital
  Aalborg, Nordjylland, Denmark
• MD

  Maria Dons, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• KB

  Katrine Bernholm, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• FD

  Filip S. Davidovski, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• LD

  Lisa S. Duus, MD

  Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark
  Copenhagen, Hovedstaden, Denmark
• CO

  Camilla I. Ottosen, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• AN

  Anne B. Nielsen, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• JB

  Julie Borchsenius, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• CE

  Caroline Espersen, MD

  Copenhagen University Hospital - Herlev and Gentofte
  Copenhagen, Hovedstaden, Denmark
• GK

  Güldas Köse, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• FF

  Frederik Fussing, MD

  Gentofte University Hospital
  Copenhagen, Hovedstaden, Denmark
• LK

  Lars Køber, MD, DMSc

  Copenhagen University Hospital – Rigshospitalet
  Copenhagen, Hovedstaden, Denmark
• SS

  Scott D. Solomon, MD

  Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  Boston, Massachusetts, United States
• JJ

  Jens Ulrik Jensen, MD, PhD

  Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark
  Copenhagen, Hovedstaden, Denmark
• CM

  Cyril Jean-Marie Martel, PhD

  SSI
  Copenhagen, Hovedstaden, Denmark
• BG

  Bradford D. Gessner, MD, MPH

  Sole Proprietor
  EpiVac Consulting
  Anchorage, Alaska, United States
• CS

  Claudia Schwarz, PhD

  Clinical Scientist Vaccines
  RWE Platform
  Vienna, Wien, Austria
• EG

  Elisa Gonzalez, MPH

  Pfizer Vaccines
  Pfizer Vaccines
  Collegeville, Pennsylvania, United States
• MS

  Mette Skovdal, Ph.D.

  Pfizer Denmark
  Ballerup, Hovedstaden, Denmark
• PZ

  Pingping Zhang, MS

  Pfizer Vaccines
  Collegeville, Pennsylvania, United States
• 

  Elizabeth Begier, MD, M.P.H.

  Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
  Pfizer Vaccines
  Dublin, Dublin, Ireland
• TB

  Tor Biering-Sørensen, MD, PhD

  Department of Cardiology, Herlev and Gentofte Hospital
  Copenhagen, Hovedstaden, Denmark